graft-versus-tumor induction therapy

BIOLOGICAL14 trials

Sponsors

University of Maryland, Baltimore, Case Comprehensive Cancer Center, Roswell Park Cancer Institute, Baylor College of Medicine, University of California, San Diego

Conditions

Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Nasal Type Extranodal NK/T-cell LymphomaAplastic AnemiaBlastic Phase Chronic Myelogenous LeukemiaBreast CancerChronic Myeloproliferative Disorders

Phase 1

T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies

CompletedNCT00080925

National Institutes of Health Clinical Center (CC)Chronic Myeloproliferative Disorders, Leukemia, Lymphoma +3

Start: 2004-02-29End: 2010-12-31Target: 20Updated: 2012-03-08

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

Milton S. Hershey Medical CenterUnspecified Childhood Solid Tumor, Protocol Specific

Start: 2004-05-31Target: 20Updated: 2013-12-18

Phase 2

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

CompletedNCT00006379

Case Comprehensive Cancer CenterChronic Myeloproliferative Disorders, Leukemia, Lymphoma +5

Start: 2000-06-30End: 2011-10-31Updated: 2011-12-08

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

CompletedNCT00053989

Roswell Park Cancer InstituteAplastic Anemia, Chronic Myeloproliferative Disorders, Fanconi Anemia +5

Start: 2002-01-29End: 2018-07-19Updated: 2020-02-10

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

TerminatedNCT00074269

University of California, San DiegoBreast Cancer

Start: 2003-07-31End: 2008-03-31Updated: 2023-06-05

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

CompletedNCT00003396

University of Maryland, BaltimoreLeukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm +1

Start: 1998-09-30End: 2002-12-31Target: 42Updated: 2019-10-17

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

CompletedNCT00262886

University of RochesterKidney Cancer

Start: 2001-08-31Target: 35Updated: 2013-06-06

Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

CompletedNCT00425802

Memorial Sloan Kettering Cancer CenterLeukemia, Lymphoma

Start: 2006-11-28End: 2016-10-28Updated: 2017-10-31

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

TerminatedNCT00818961

Northside Hospital, Inc.Leukemia, Lymphoma, Myelodysplastic/Myeloproliferative Diseases +1

Start: 2005-05-31End: 2012-03-31Updated: 2013-12-18

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

TerminatedNCT01044745

University of NebraskaAccelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission +108

Start: 2009-12-10End: 2017-10-10Updated: 2023-09-06

Unknown Phase

Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation

CompletedNCT00073879

Baylor College of MedicineKidney Cancer

Start: 2003-04-30End: 2004-04-30Updated: 2015-01-29

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

TerminatedNCT00255684

University of RochesterChronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia +4

Start: 2003-12-31End: 2016-06-30Updated: 2016-11-03

Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer

CompletedNCT00290641

Masonic Cancer Center, University of MinnesotaChronic Myeloproliferative Disorders, Leukemia, Lymphoma +1

Start: 2001-04-30End: 2006-01-31Updated: 2017-11-29

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

University of California, San FranciscoChronic Myeloproliferative Disorders, Kidney Cancer, Leukemia +4

Start: 2005-05-31Target: 35Updated: 2014-01-06